OpenVSafe by OpenVAERS
Search V-safe

XV2-57858-32922

2 vaccinations 2 coded responses 14 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
46-50
ZIP prefix
483 / MI
Registered
2020-12-22
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-22
    Registered in v-safe
  2. 2020-12-22
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-22
    Health check-in — 0 day, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2020-12-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2020-12-29
    Health check-in — 7 day, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-05
    Health check-in — 14 day, dose 1
    Feeling: Good
    Adult check-in
  7. 2021-01-13
    Dose 2 — Pfizer-BioNTech
  8. 2021-01-19
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dysuria, Unevaluable event, Vulvovaginal pain, Vulvovaginal rash, Vulvovaginal swelling — Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  9. 2021-01-19
    Report sent to call center — days 1–6 daily, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  10. 2021-01-20
    Health check-in — 7 day, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-01-27
    Health check-in — 14 day, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-02-03
    Health check-in — 21 day, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-02-10
    Health check-in — 28 day, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-02-17
    Health check-in — 35 day, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-02-24
    Health check-in — 42 day, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-03-24
  17. 2021-04-14
    Health check-in — 3 month, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-07-14
    Health check-in — 6 month, dose 2
    Feeling: Good
    Adult check-in
  19. 2022-01-13
    Survey response — 12 month, dose 2
    MedDRA: COVID-19, Depressed mood, Fatigue, Impaired work ability — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    MedDRA releases: 2024-11 · check-in answers available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-22Pfizer-BioNTech
22021-01-13Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2021-01-19 Unsuccessful

Free text

Release 2

Systemic reaction (other): I got a severe vaginal rash, pain and swelling on Friday (1/15/21) night which caused pain with urination that did not begin to subside until today, 1/19/21. Ive made a gynecology appointment for 1/20/21.
Healthcare visit (other): I cannot get into my Gynecologist until 1/20/21

Release 10

Symptoms: I was positive for covid 19 on 11/19/21. Got a booster 11/16/21 but was around a lot of people 11/13/21. I was off work for 2 weeks. I still feel Fatigue and some melancholy. RN job not affected. Working part time.

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event ✓ ✓ ✓
SDCOVID-19 · · ✓
SDDepressed mood · · ✓
SDFatigue · · ✓
SDImpaired work ability · · ✓
SRODysuria ✓ · ✓
SROPain ○ · ○
SROSwelling ○ · ○
SROUnevaluable event ○ ✓ ○
SROVulvovaginal pain ✓ · ✓
SROVulvovaginal rash ✓ · ✓
SROVulvovaginal swelling ✓ · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release